SAMPLE REPORT
1066 Estrogen-META® (Urine)
This evaluation analyzes the condition of 2-stage female sex hormone metabolism in liver. Female sex hormone metabolite, if balance in its concentration, will protect the body from disease, while if imbalanced will cause disease such as breast, cervical and prostate cancer. Through the detailed data of female sex hormone metabolite will help women having medical challenge restore and improve the hormone metabolism, as well as prevent the hormone-related disease.
SAMPLE REPORT
Testing Content
Estrogen metabolism assessment involves measuring the levels of estrogen metabolites in urine, including phase I hydroxylation metabolites and phase II methylation metabolites.
Estrogen Metabolites | Balance of Phase I Hydroxylated Metabolites | Balance of Phase II Methylated Estrogen Metabolites |
---|---|---|
2-Hydroxyestrone 4-Hydroxyestrone 16α-Hydroxyestrone 2-Methyoxyestrone | 2-Hydroxyestrone / 16α-Hydroxyestrone Ratio 2-OHE1/16α-OHE1 Ratio | 2-Methoxyestrone to 2-Hydroxyestrone Ratio 2-MeOE1/2-OHE1 Ratio |
Estrogen metabolism is primarily carried out by the liver in two phases:
Phase I
Hydroxylation In this phase, estrogen undergoes hydroxylation reactions catalyzed by cytochrome P450 enzymes, resulting in hydroxylated metabolites such as 2-hydroxyestrone and 4-hydroxyestrone.
Phase II
Conjugation The hydroxylated metabolites are further metabolized through conjugation reactions, including:
Methylation
Methyl groups are added to the metabolites, forming methylated estrogens.
Glucuronidation;
Glucuronic acid is attached to the metabolites, increasing their water solubility.
Sulfation
Sulfate groups are added, forming sulfate conjugates.
Glutathione Conjugation
Glutathione is conjugated to the metabolites, facilitating their excretion. These conjugated metabolites are then excreted from the body through urine and feces.
Estrogen-META® disorders can easily lead to | |
---|---|
anxiety/irritability | menorrhagia |
endometriosis | premenstrual syndrome |
menopausal Symptoms | osteoporosis |
polycystic ovarian syndrome | head and neck cancers |
pre-eclampsia | uterine fibroids |
uterine cancers | cervical cancer |
ovarian cancer | breast cancer |
prostate cancer |
The important information provided by Estrogen-META® is as follows
Understanding Estrogen Detoxification
Assessing whether estrogen detoxification pathways are functioning properly helps determine if estrogen metabolites are balanced. Balanced estrogen metabolism can have protective effects, while imbalances may increase the risk of conditions such as breast cancer, uterine fibroids, osteoporosis, and prostate cancer.
The Role of Methylation in Estrogen Metabolism
Methylation is a key step in estrogen metabolism. It protects 2-hydroxyestrone (2-OHE1) and facilitates the metabolism of 4-hydroxyestrone (4-OHE1). Effective methylation helps eliminate carcinogenic estrogen metabolites and activates protective hormones to counteract cancer.
Analyzing Estrogen Metabolism and Metabolites
Analyzing estrogen metabolism and metabolites deepens our understanding of hormone excess or deficiency, aiding in the selection of personalized bioidentical hormone therapy and monitoring its effectiveness and safety, as well as developing personalized health plans.
Further Treatment Options
Subsequent treatments may include estrogen metabolism genetic analysis (Estro Genomics) to understand genetic constitutions (genotype) and modify environmental expressions (phenotype) that may affect estrogen metabolism.